21 May 2013
Keywords: millennium/j, velcade, launched, uk, millennium/johnson, johnson, bortezomib
Article | 24 May 2004
Millennium/Johnson & Johnson's Velcade (bortezomib) is now available in the UK for the treatment of patients with multiple myeloma who ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.